POLICY IMPACT COMMUNICATIONS, INC.

Lobbying for CHROMADEX · Niagen bioscience focusing on the potential of NAD+.

Filing 2nd Quarter - Amendment

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Aug 15, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Protecting DSHEA.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.